Opus Genetics Q3 EPS $(0.46) Misses $(0.15) Estimate, Sales $1.137M Miss $1.959M Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings Misses
Opus Genetics (NASDAQ:IRD) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.15) by 206.67 percent. This is a 84 percent decrease over losses of $(0.25) per share from the
Opus Genetics (NASDAQ:IRD) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.15) by 206.67 percent. This is a 84 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $1.137 million which missed the analyst consensus estimate of $1.959 million by 41.97 percent. This is a 63.07 percent decrease over sales of $3.079 million the same period last year.